Product Information

DROSP-EE-LEVOMEF 3-0.02-0.451 is a generic product labeled by Sandoz Inc., priced at $1.5617 per EA under NDC 00781407515. Its NADAC has been published 488 times since Feb 22, 2017.

Manufacturer

Sandoz Inc.

NDC

00781407515

Classification

Generic

Dosage Form

KIT

Last Updated

6/17/2026

Approval Type

Authorized Generic (NDA)

FDA Application

NDA022532

On Market Since

10/12/2016

Price Statistics

The NADAC for DROSP-EE-LEVOMEF 3-0.02-0.451 has been published 488 times since Feb 22, 2017, and over the history we have for it it has declined 61.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5617 per EA
All-time high$4.5285 (Apr 13, 2022)
All-time low$1.2304 (Jul 17, 2024)
52-week high$1.8184
52-week low$1.2523
Median price$3.3503
Average price$3.0003
Largest weekly change-47.8% (Apr 17, 2024)
Weeks tracked488
Tracking sinceFeb 22, 2017

Price History

1W

0.0%

1M

-4.3%

3M

+8.9%

6M

+24.7%

1Y

-14.1%

3Y

-35.3%

5Y

-58.4%

All

-61.7%

Generic Alternatives

The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DROSP-EE-LEVOMEF 3-0.02-0.451?

The current National Average Drug Acquisition Cost (NADAC) for DROSP-EE-LEVOMEF 3-0.02-0.451, manufactured by Sandoz Inc., is $1.5617 per EA (NDC 00781407515), effective Jun 24, 2026.

How has the price of DROSP-EE-LEVOMEF 3-0.02-0.451 changed over time?

Over the history we have for it, the NADAC for DROSP-EE-LEVOMEF 3-0.02-0.451 has declined 61.7%. It has been tracked across 488 weekly CMS publications since Feb 22, 2017.

What are the highest and lowest recorded NADAC prices for DROSP-EE-LEVOMEF 3-0.02-0.451?

Since Feb 22, 2017, the NADAC for DROSP-EE-LEVOMEF 3-0.02-0.451 has ranged from a low of $1.2304 (Jul 17, 2024) to a high of $4.5285 (Apr 13, 2022), with a median of $3.3503 per EA.

Are there cheaper alternatives to DROSP-EE-LEVOMEF 3-0.02-0.451?

2 NADAC-published products share the same active ingredient, strength, and dosage form as DROSP-EE-LEVOMEF 3-0.02-0.451, but none are currently priced below it.

Who manufactures DROSP-EE-LEVOMEF 3-0.02-0.451?

DROSP-EE-LEVOMEF 3-0.02-0.451 (NDC 00781407515) is labeled by Sandoz Inc., and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.